7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Identification of drug candidates targeting monocyte reprogramming in people living with HIV

      research-article
      1 , 2 , 1 , 2 , 3 , 4 , 1 , 2 , 3 , 4 , 1 , 1 , 1 , 5 , 1 , 6 , 1 , 3 , 4 , 3 , 4 , 3 , 4 , 7 , 8 , 9 , 10 , 11 , 1 , 1 , 10 , 3 , 4 , 12 , 3 , 4 , 13 , 3 , 4 , 1 , 2 , 10 , 1 ,
      Frontiers in Immunology
      Frontiers Media S.A.
      systems immunology, transcriptomics, HIV, monocytes, inflammation, drug repurposing

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          People living with HIV (PLHIV) are characterized by functional reprogramming of innate immune cells even after long-term antiretroviral therapy (ART). In order to assess technical feasibility of omics technologies for application to larger cohorts, we compared multiple omics data layers.

          Methods

          Bulk and single-cell transcriptomics, flow cytometry, proteomics, chromatin landscape analysis by ATAC-seq as well as ex vivo drug stimulation were performed in a small number of blood samples derived from PLHIV and healthy controls from the 200-HIV cohort study.

          Results

          Single-cell RNA-seq analysis revealed that most immune cells in peripheral blood of PLHIV are altered in their transcriptomes and that a specific functional monocyte state previously described in acute HIV infection is still existing in PLHIV while other monocyte cell states are only occurring acute infection. Further, a reverse transcriptome approach on a rather small number of PLHIV was sufficient to identify drug candidates for reversing the transcriptional phenotype of monocytes in PLHIV.

          Discussion

          These scientific findings and technological advancements for clinical application of single-cell transcriptomics form the basis for the larger 2000-HIV multicenter cohort study on PLHIV, for which a combination of bulk and single-cell transcriptomics will be included as the leading technology to determine disease endotypes in PLHIV and to predict disease trajectories and outcomes.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

          In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate numbers, discreteness, large dynamic range and the presence of outliers require a suitable statistical approach. We present DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression. The DESeq2 package is available at http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html. Electronic supplementary material The online version of this article (doi:10.1186/s13059-014-0550-8) contains supplementary material, which is available to authorized users.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gene Ontology: tool for the unification of biology

            Genomic sequencing has made it clear that a large fraction of the genes specifying the core biological functions are shared by all eukaryotes. Knowledge of the biological role of such shared proteins in one organism can often be transferred to other organisms. The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells is accumulating and changing. To this end, three independent ontologies accessible on the World-Wide Web (http://www.geneontology.org) are being constructed: biological process, molecular function and cellular component.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              STAR: ultrafast universal RNA-seq aligner.

              Accurate alignment of high-throughput RNA-seq data is a challenging and yet unsolved problem because of the non-contiguous transcript structure, relatively short read lengths and constantly increasing throughput of the sequencing technologies. Currently available RNA-seq aligners suffer from high mapping error rates, low mapping speed, read length limitation and mapping biases. To align our large (>80 billon reads) ENCODE Transcriptome RNA-seq dataset, we developed the Spliced Transcripts Alignment to a Reference (STAR) software based on a previously undescribed RNA-seq alignment algorithm that uses sequential maximum mappable seed search in uncompressed suffix arrays followed by seed clustering and stitching procedure. STAR outperforms other aligners by a factor of >50 in mapping speed, aligning to the human genome 550 million 2 × 76 bp paired-end reads per hour on a modest 12-core server, while at the same time improving alignment sensitivity and precision. In addition to unbiased de novo detection of canonical junctions, STAR can discover non-canonical splices and chimeric (fusion) transcripts, and is also capable of mapping full-length RNA sequences. Using Roche 454 sequencing of reverse transcription polymerase chain reaction amplicons, we experimentally validated 1960 novel intergenic splice junctions with an 80-90% success rate, corroborating the high precision of the STAR mapping strategy. STAR is implemented as a standalone C++ code. STAR is free open source software distributed under GPLv3 license and can be downloaded from http://code.google.com/p/rna-star/.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/1763927Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/795596Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1972550Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2562141Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2535126Role: Role: Role: Role: Role:
                Role: Role:
                URI : https://loop.frontiersin.org/people/795566Role: Role: Role: Role:
                Role: Role:
                URI : https://loop.frontiersin.org/people/2404283Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2525496Role: Role:
                URI : https://loop.frontiersin.org/people/1241539Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1204818Role: Role:
                URI : https://loop.frontiersin.org/people/588727Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1908488Role: Role:
                URI : https://loop.frontiersin.org/people/1906442Role: Role:
                URI : https://loop.frontiersin.org/people/806407Role: Role: Role:
                URI : https://loop.frontiersin.org/people/22651Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/500291Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/200727Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/65426Role: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1196852Role: Role: Role: Role: Role: Role: Role: Role: Role:
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                20 November 2023
                2023
                : 14
                : 1275136
                Affiliations
                [1] 1Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) , Bonn, Germany
                [2] 2Genomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn , Bonn, Germany
                [3] 3Department of Internal Medicine, Radboud University Medical Center , Nijmegen, Netherlands
                [4] 4Radboud Center for Infectious Diseases, Radboud University Medical Center , Nijmegen, Netherlands
                [5] 5Systems Hematology, Stem Cells & Precision Medicine, Max Delbrück Center - Berlin Institute for Medical Systems Biology (MDCBIMSB) , Berlin, Germany
                [6] 6In Vivo Cell Biology of Infection, Max Planck Institute for Infection Biology (MPIIB) , Berlin, Germany
                [7] 7Broad Institute at Massachusetts Institute of Technology (MIT) and Harvard , Boston, MA, United States
                [8] 8Ragon Institute of Mass General Hospital (MGH), MIT, and Harvard , Cambridge, MA, United States
                [9] 9Department of Chemistry, Institute for Medical Engineering and Science, Koch Institute , Cambridge, MA, United States
                [10] 10Platform for Single Cell Genomics and Epigenomics (PRECISE), DZNE and University of Bonn , Bonn, Germany
                [11] 11Institute for Human Genetics, University Hospital Schleswig-Holstein , Lübeck, Germany
                [12] 12Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn , Bonn, Germany
                [13] 13Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania
                Author notes

                Edited by: Ying Zhu, Genentech Inc., United States

                Reviewed by: Aurobind Vidyarthi, Yale University, United States; Soumya Panigrahi, Case Western Reserve University, United States

                *Correspondence: Anna C. Aschenbrenner, anna.aschenbrenner@ 123456dzne.de

                †These authors share senior authorship

                Article
                10.3389/fimmu.2023.1275136
                10703486
                38077315
                b37567af-56e1-42b2-81d7-4639cdda687a
                Copyright © 2023 Knoll, Bonaguro, dos Santos, Warnat-Herresthal, Jacobs-Cleophas, Blümel, Reusch, Horne, Herbert, Nuesch-Germano, Otten, van der Heijden, van de Wijer, Shalek, Händler, Becker, Beyer, Netea, Joosten, van der Ven, Schultze and Aschenbrenner

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 09 August 2023
                : 18 October 2023
                Page count
                Figures: 4, Tables: 0, Equations: 0, References: 75, Pages: 15, Words: 7425
                Funding
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the German Research Foundation (DFG) (INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, EXC2151 – 390873048; and SFB1454 – 432325352 to JS); Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big to JS and MN); EU projects SYSCID (733100 to JS); ERA CVD (00160389 to JS); ImmunoSep (847422 to JS); AA is supported by DFG under AS 637/1-1; AS 637/2-1; AS 637/3-1 and SFB1454 (432325352) and by the BMBF under IMMME/01EJ2204D. The 2000-HIV study is supported by an unrestricted grant from ViiV Healthcare (to AV, M.G.N., LJ). MN is supported by an ERC Advanced Grant (833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research.
                Categories
                Immunology
                Original Research
                Custom metadata
                Systems Immunology

                Immunology
                systems immunology,transcriptomics,hiv,monocytes,inflammation,drug repurposing
                Immunology
                systems immunology, transcriptomics, hiv, monocytes, inflammation, drug repurposing

                Comments

                Comment on this article